Murphy Pohlad Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Murphy Pohlad Asset Management LLC

$251 Million
Q3 2025

A detailed history of Murphy Pohlad Asset Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Murphy Pohlad Asset Management LLC holds 3,433 shares of REGN stock, worth $2.38 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

3,433

Previous 1,580 117.28%

Holding current value

$2.38 Million

Previous $829,000 132.81%

% of portfolio

0.77%

Previous 0.35%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	BUY	$534.91 - $598.71 $991,188 - $1.11 Million	1,853 Added 117.28%	3,433 $1.93 Million
Q2 2025 Aug 04, 2025	SELL	$483.07 - $625.6 $9,661 - $12,512	-20 Reduced 1.25%	1,580 $829,000
Q3 2024 Oct 28, 2024	SELL	$1024.09 - $1201.76 $102,408 - $120,176	-100 Reduced 5.88%	1,600 $1.68 Million
Q2 2024 Jul 17, 2024	SELL	$883.2 - $1071.19 $149,260 - $181,031	-169 Reduced 9.04%	1,700 $1.79 Million
Q1 2024 Apr 12, 2024	SELL	$902.69 - $993.35 $4,513 - $4,966	-5 Reduced 0.27%	1,869 $1.8 Million

Q4 2023 Jan 19, 2024	SELL	$775.18 - $881.7 $864,325 - $983,095	-1,115 Reduced 37.3%	1,874 $1.65 Million
Q3 2023 Oct 10, 2023	SELL	$692.45 - $844.37 $90,018 - $109,768	-130 Reduced 4.17%	2,989 $2.46 Million
Q2 2023 Jul 20, 2023	SELL	$700.03 - $830.35 $120,405 - $142,820	-172 Reduced 5.23%	3,119 $2.24 Million
Q1 2023 Apr 17, 2023	SELL	$680.49 - $826.97 $84,380 - $102,544	-124 Reduced 3.63%	3,291 $2.7 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $83,295 - $90,434	-118 Reduced 3.34%	3,415 $2.46 Million
Q3 2022 Oct 24, 2022	SELL	$573.97 - $724.32 $57,397 - $72,432	-100 Reduced 2.75%	3,533 $2.43 Million
Q2 2022 Aug 03, 2022	SELL	$548.35 - $738.84 $27,417 - $36,942	-50 Reduced 1.36%	3,633 $2.15 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $48,913 - $60,387	-90 Reduced 2.39%	3,683 $2.33 Million
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $554,512 - $657,807	966 Added 34.41%	3,773 $2.28 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $35,460 - $41,890	75 Added 2.75%	2,807 $1.57 Million
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $57,198 - $69,112	105 Added 4.0%	2,732 $1.53 Million
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $125,796 - $164,199	255 Added 10.75%	2,627 $1.64 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $797,418 - $1.17 Million	2,372 New	2,372 $1.16 Million

Others Institutions Holding REGN

# of Institutions

1,466

Shares Held

86.5M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Pohlad Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Pohlad Asset Management LLC with notifications on news.

Account

Murphy Pohlad Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History